Last Updated: 01/03/2024

Novel oral combination formulation for the treatment of resistant malaria (Plasmodium falciparum) comprising a/ß arteether and Lumifantrine

Objectives

This project explores a novel oral combination formulation for the treatment of resistant malaria (Plasmodium falciparum) comprising a/ß arteether and Lumifantrine.

Principal Investigators / Focal Persons

Prabhat R. Mishra

Date

Mar 2019 — Mar 2022

Total Project Funding

$36,816

Funding Details
Department of Biotechnology (DBT)

Grant ID: BT/HRD/35/01/03/2019
Project Site

India

SHARE

Related Resources

Related Projects

SHARE